Medical Management of Inflammatory Bowel Disease.
Surg Clin North Am
; 99(6): 1223-1235, 2019 Dec.
Article
in En
| MEDLINE
| ID: mdl-31676060
Inflammatory bowel disease has become a growing concern worldwide. The chronic and progressive nature of inflammatory bowel disease poses significant challenges to the treatment and management of affected patients, straining health care resources. Therapeutic options and optimal management strategies have evolved dramatically. The treat-to-target strategy has shifted focus toward identifiable and attainable treatment targets and with the ability to optimize tight control. Advancements in our understanding of the pathophysiology led to therapeutic mechanisms that have a more narrowed focus toward gut-specific targets, improving safety profiles.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Inflammatory Bowel Diseases
/
Conservative Treatment
/
Immunosuppressive Agents
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Surg Clin North Am
Year:
2019
Document type:
Article
Country of publication:
United States